Madison Elsady
Analyst, B. Riley
Replay available
Eton Pharmaceuticals, Inc. (NASDAQ: ETON) Q1 2025 earnings conference call, held 2025-05-13. Replay captured from the company's public earnings webcast.

Analyst, B. Riley
Chief Executive Officer
Analyst, Crate Harlem
Watch the replay and follow the connected company analysis, news, and investor updates for Eton Pharmaceuticals, Inc..
WEBVTT 00:00:00.031 -- 00:00:05.294 And welcome to the IN Pharmaceuticals First Quarter 2025 Financial Results Conference 00:00:05.294 -- 00:00:09.397 call. At this time, all participants are in the listen-only mode. 00:00:09.397 -- 00:00:13.179 Following the formal remarks, we will open the call out for your questions. 00:00:13.179 -- 00:00:17.442 Please be advised that this call is being recorded at the company's request. 00:00:17.442 -- 00:00:22.545 At this time, I'd like to turn it over to David Kempa, Chief Business Officer at 00:00:22.545 -- 00:00:26.046 IN Pharmaceuticals. Please proceed. 00:00:26.568 -- 00:00:31.005 Thank you, Operator. Good afternoon, everyone, and welcome to Eaton's first quarter of 00:00:31.005 -- 00:00:36.157 2025 conference call. This afternoon, we issued a press release that 00:00:36.157 -- 00:00:39.819 outlines the topics we plan to discuss on today's call. 00:00:39.819 -- 00:00:43.701 The release is available on our website, EatonPharma.com. 00:00:43.701 -- 00:00:48.764 Joining me on our call today, we have Shawn Brangelson, our CEO, James Gruber, 00:00:48.764 -- 00:00:53.527 our CFO, and Ipek Trinkas, our Chief Commercial Officer. 00:00:53.527 -- 00:00:57.629 In addition to taking live questions on today's call, we will be answering questions 00:00:57.629 -- 00:01:02.951 that are emailed to us. Investors can send their questions to investorrelations 00:01:02.951 -- 00:01:05.051 at eatonpharma.com. 00:01:05.051 -- 00:01:10.133 Before we begin, I would like to remind everyone that remarks made during this call may 00:01:10.133 -- 00:01:15.194 contain forward-looking statements and involve risks and uncertainties that could cause 00:01:15.194 -- 00:01:20.515 actual results to differ materially from those contained in these forward-looki...